Literature DB >> 1618547

Oxygen free radicals and cardiac reperfusion abnormalities.

J I Goldhaber1, J N Weiss.   

Abstract

Oxygen free radicals are highly reactive compounds causing peroxidation of lipids and proteins and are thought to play an important role in the pathogenesis of reperfusion abnormalities including myocardial stunning, irreversible injury, and reperfusion arrhythmias. Free radical accumulation has been measured in ischemic and reperfused myocardium directly using techniques such as electron paramagnetic resonance spectroscopy and tissue chemiluminescence and indirectly using biochemical assays of lipid peroxidation products. Potential sources of free radicals during ischemia and reperfusion have been identified in myocytes, vascular endothelium, and leukocytes. In several different experimental models exogenous free radical-generating systems have been shown to produce alterations in cardiac function that resemble the various reperfusion abnormalities described above. Injury to processes involved in regulation of the intracellular Ca2+ concentration may be a common mechanism underlying both free radical-induced and reperfusion abnormalities. Direct effects of free radicals on each of the known Ca(2+)-regulating mechanisms of the cell as well as the contractile proteins and various ionic membrane currents have been described. Free radicals also inhibit critical enzymes in anaerobic and aerobic metabolic pathways, which may limit the metabolic reserve of reperfused myocardium and contribute to intracellular Ca2+ overload. Inhibiting free radical accumulation during myocardial ischemia/reperfusion with free radical scavengers and inhibitors has been demonstrated to reduce the severity of myocardial stunning, irreversible injury, and reperfusion arrhythmias in many, but not all, studies. This evidence strongly implicates free radical accumulation during myocardial ischemia/reperfusion as an important pathophysiological mechanism of reperfusion abnormalities, although many issues remain unresolved.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618547     DOI: 10.1161/01.hyp.20.1.118

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

1.  Effects of hypoxia, simulated ischemia and reoxygenation on the contractile function of human atrial trabeculae.

Authors:  A Lammerich; J Bohm; I Schimke; K D Wagner; E Storch; J Günther
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.

Authors:  Wangde Dai; Elissa Cheung; Rick J Alleman; Justin B Perry; Mitchell E Allen; David A Brown; Robert A Kloner
Journal:  Cardiovasc Drugs Ther       Date:  2016-12       Impact factor: 3.727

Review 3.  Prospects for the use of antioxidant therapies.

Authors:  S R Maxwell
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

Review 4.  Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.

Authors:  M J Kendall; I Rajman; S R Maxwell
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

5.  Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.

Authors:  Suresh K Gupta; Amit Saxena; Uma Singh; Dharamvir S Arya
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

6.  Halothane suppresses the increase in intracellular calcium concentration of isolated rat myocytes during hydrogen peroxide perfusion.

Authors:  Akihiko Nonaka; Satoshi Kashimoto; Hironobu Iwashita; Teruo Kumazawa
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

Review 7.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

8.  Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase.

Authors:  Pratima Tripathi; M Chandra; Mithilesh K Misra
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

Review 9.  Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer.

Authors:  Eric E Essick; Flora Sam
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

10.  Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo.

Authors:  X-Y Zhao; G-Y Li; Y Liu; L-M Chai; J-X Chen; Y Zhang; Z-M Du; Y-J Lu; B-F Yang
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.